Search
for
Sort by
Research 31–60 of 33
- Alopecia Associated to the Use of Disease-Modifying Therapies for Multiple Sclerosis: A Scoping Review Protocol
- BIO-ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FINASTERIDE, TADALAFIL, AND ITS APPLICATION TO PHARMACOKINETIC STUDIES IN RAT PLASMA BY USING LC-MS/MS
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
- Teriflunomide in multiple sclerosis: an update
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- “Nail loss after teriflunomide treatment: A new potential adverse event”
- Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?
- Hair Loss Associated with Teriflunomide Treatment
- Teriflunomida and hair disorders
- Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
- Tether-induced tenosynovitis: The importance of an intact skin barrier
- Differential impact of environmental factors on systemic and localized autoimmunity
- Combined Ultrasound and Microneedle for Enhanced Transdermal Delivery: Synergistic Mechanisms and Therapeutic Advances
- Leflunomide: an unlikely trigger and mechanistically a beneficial drug for alopecia areata
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- STABILITY INDICATING AN LC-ESI-MS/MS METHOD FOR THE QUANTIFICATION OF MINOXIDIL IN PHARMACEUTICAL DOSAGE FORMS
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Dissolving microneedles: an advanced approach for transdermal drug delivery
- Tapinarof cream for atopic dermatitis: Pharmacokinetics, systemic exposure, and preliminary efficacy/safety results
- Targeting nonmelanoma skin cancer using selective photothermolysis with 595 nm pulsed dye laser: Outcomes of 1080 cases
- Hair loss due to treatment of multiple sclerosis
- Diffuse hair loss: Its triggers and management
- Leflunomide-Induced Cutaneous Ulcers: A Rare Diagnostic Conundrum
- ORLISTAT
- Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes